TrialJournal of human hypertension2006

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.

A G Johnson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.